Cargando…

Unraveling the Mechanism of the Antitumor Activity of Bacillus Calmette-Guérin

Our understanding of the mechanism of bacillus Calmette-Guérin (BCG) in controlling urothelial carcinoma is still evolving. Studies have revealed a complex and multifaceted immune response. BCG-elicited adaptive antitumor immunity directed towards tumor antigens could have major implications for tri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Roger, Gilbert, Scott M., Kamat, Ashish M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. on behalf of European Association of Urology. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448869/ https://www.ncbi.nlm.nih.gov/pubmed/32861573 http://dx.doi.org/10.1016/j.eururo.2020.08.027

Ejemplares similares

COVID-19 and Bacillus Calmette-Guérin: What is the Link?
por: Hegarty, Paul K., et al.
Publicado: (2020)

Bacillus Calmette–Guérin Immunotherapy for Cancer
por: Cardillo, Fabíola, et al.
Publicado: (2021)

Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 – what’s old is new again?
por: O'Connor, Ellen, et al.
Publicado: (2020)

VARIABILITY OF BCG STRAINS (BACILLUS CALMETTE-GUÉRIN)
por: Suter, W. Emanuel, et al.
Publicado: (1951)

Bacillus Calmette-Guerin (BCG) vaccine in Iran
por: Fallah, Fatemeh, et al.
Publicado: (2018)

Clinical Course of Bacillus Calmette-Guerin Lymphadenitis
por: Ko, Dayoung, et al.
Publicado: (2022)

Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity
por: Parmar, Kanak, et al.
Publicado: (2021)

100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19
por: Lobo, Niyati, et al.
Publicado: (2021)

Predictive biomarkers of response to bacillus Calmette‐Guérin immunotherapy and bacillus Calmette‐Guérin failure for non‐muscle invasive bladder cancer
por: Wang, Ziting, et al.
Publicado: (2022)

Disseminated Bacillus Calmette-Guérin Infection and Immunodeficiency
por: Bernatowska, Ewa Anna, et al.
Publicado: (2007)

Bacillus Calmette-Guerin (BCG): the adroit vaccine
por: Adesanya, Oluwafolajimi A., et al.
Publicado: (2021)

100 years of the Bacillus Calmette-Guérin vaccine
por: Bettencourt, Paulo J.G., et al.
Publicado: (2021)

THE HOST RESPONSE TO CALMETTE-GUÉRIN BACILLUS INFECTION IN MICE
por: Blanden, R. V., et al.
Publicado: (1969)

Letter to the Editor: Bacillus Calmette-Guerin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease
por: Li, Roger, et al.
Publicado: (2017)

Sternal Osteomyelitis after Bacillus Calmette-Guérin Vaccination
por: Selvestravičius, Rolandas, et al.
Publicado: (2016)

Association of Polymorphisms in Oxidative Stress Genes with Clinical Outcomes for Bladder Cancer Treated with Bacillus Calmette-Guérin
por: Wei, Hua, et al.
Publicado: (2012)

Bacillus Calmette-Guérin in the management of superficial bladder cancer
por: Kapoor, Rakesh, et al.
Publicado: (2008)

Bacillus Calmette–Guérin in Immuno-Regulation of Alzheimer’s Disease
por: Klein, Benjamin Y., et al.
Publicado: (2022)

An ambivalent prostate nodule after Bacillus Calmette-Guérin therapy
por: Sauvat, L., et al.
Publicado: (2021)

Recognition and destruction of Bacillus Calmette-Guerin-infected human monocytes
Publicado: (1993)

Bacillus Calmette-Guérin vaccine-related complications in children in Oman
por: Al Waili, Badria, et al.
Publicado: (2021)

Newly sequenced genomes of four Bacillus Calmette Guerin vaccines
por: Sisco, Maria Carolina, et al.
Publicado: (2020)

Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update
por: Guallar-Garrido, Sandra, et al.
Publicado: (2020)

Tuberculous Spondylitis Caused by Intravesical Bacillus Calmette-Guerin Therapy
por: Minakata, Tomokazu, et al.
Publicado: (2020)

Oral bacillus Calmette-Guérin vaccine against tuberculosis: why not?
por: Monteiro-Maia, Renata, et al.
Publicado: (2014)

Managing the adverse events of intravesical bacillus Calmette–Guérin therapy
por: Decaestecker, Karel, et al.
Publicado: (2015)

Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
por: Al-Hammadi, Suleiman, et al.
Publicado: (2017)

Erythema at the bacillus Calmette-Guerin scar after influenza vaccination
por: Chavarri-Guerra, Yanin, et al.
Publicado: (2019)

Severity of COVID-19 in bacillus Calmette-Guérin vaccinated population
por: Khanum, Iffat, et al.
Publicado: (2021)

Reactive Arthritis After Intravesical Bacillus Calmette-Guérin Therapy
por: Taniguchi, Yoshinori, et al.
Publicado: (2022)

Bacillus Calmette-Guérin (BCG) Brazilian Backstage in Bladder Cancer
Publicado: (2021)

Prognostic impact of Bacillus Calmette-Guérin interruption at the time of induction and consolidation
por: Alhogbani, M. Mofarej, et al.
Publicado: (2017)

Genetic variants in the inflammation pathway as predictors of recurrence and progression in non-muscle invasive bladder cancer treated with Bacillus Calmette–Guérin
por: Williams, Stephen B., et al.
Publicado: (2017)

The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine
por: Li, Junli, et al.
Publicado: (2021)

Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
por: Saban, Marcia R, et al.
Publicado: (2007)

Pleural Effusion Caused by Bacillus Calmette-Guérin Immunotherapy for Bladder Cancer
por: Rachakonda, Tara, et al.
Publicado: (2017)

Past, Present and Future of Bacillus Calmette-Guérin Vaccine Use in China
por: Li, Junli, et al.
Publicado: (2022)

Effectiveness of bacillus Calmette–Guerin vaccination history on pulmonary tuberculosis symptoms
por: Farajnia, Safar, et al.
Publicado: (2019)

Positive impact of rescheduling Bacillus Calmette-Guérin vaccination on vaccinations at birth
por: Oberoi, Simmi, et al.
Publicado: (2017)

Intravesical bacillus Calmette-Guérin for bladder cancer: are all the strains equal?
por: D’Andrea, David, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3qudn83bqq0bu5r94rm3rodou9